Chair: D. Linz (Maastricht, NL), K. Odening (Bern, CH)
| 09:45 | (V439) | Introduction |
| D. Linz (Maastricht, NL) | ||
| 09:50 | (V440) | How can we computationally determine novel drug targets for atrial fibrillation? |
| S. Meier (Maastricht, NL) | ||
| 10:05 | Discussion | |
| 10:10 | (V441) | How can we make drugs more specific? – Faster drug testing in cardiac cellular electrophysiology |
| N. Voigt (Göttingen) | ||
| 10:25 | Discussion | |
| 10:30 | (V442) | Which targets other than ion channels can help to prevent arrhythmias? – Targeting the microbiome? |
| R. Schnabel (Hamburg) | ||
| 10:45 | Discussion | |
| 10:50 | (V443) | Can gene-therapy approaches cure arrhythmia disorders? |
| L. Giammarino (Bern, CH) | ||
| 11:05 | Discussion | |
| 11:10 | (V444) | Conclusion |
| K. Odening (Bern, CH) |
